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Detection of
Newly Described
Astrovirus MLB1 in
Stool Samples
from Children
Stacy R. Finkbeiner, Binh-Minh Le, Lori R. Holtz,
Gregory A. Storch, and David Wang
The prevalence of the recently identified astrovirus
MLB1 in a cohort of children with diarrhea in St. Louis, Missouri, USA, was defined by reverse transcription–PCR. Of
254 stool specimens collected in 2008, 4 were positive for
astrovirus MLB1. These results show that astrovirus MLB1
is circulating in North America.

A

stroviruses infect a variety of hosts, including humans,
turkeys, chicken, cattle, sheep, dogs, cats, deer, ducks,
and bats (1,2). The 8 known human serotypes are genetically closely related. Astroviruses typically cause diarrhea
in their hosts; in humans, symptoms usually last 2–4 days
(3). Children <2 years of age, elderly persons, or otherwise
immunocompromised persons are most commonly affected
(3). Epidemiologic studies suggest human astroviruses 1–8
are responsible for up to ≈10% of cases of acute, nonbacterial diarrhea in children (4–8).
Recently, a highly divergent astrovirus, referred to as
astrovirus MLB1 (AstV-MLB1), was identified in the stool
of a 3-year-old boy in Australia (9). The entire genome of
this novel virus was subsequently sequenced and characterized (10). No published reports have described AstV-MLB1
outside of the index case. In this study, we determined the
prevalence of this novel virus by reverse transcription–
PCR (RT-PCR) screening of stool samples collected at the
St. Louis Children’s Hospital in St. Louis, Missouri.
The Study
Pediatric stool specimens sent for bacterial culture to
the clinical microbiology laboratory at the St. Louis Children’s Hospital were analyzed for AstV-MLB1. The Human Research Protection Office of Washington University
in St. Louis approved this study. Samples were collected
during January through May 2008. Stools were diluted in
phosphate-buffered saline at a 1:6 ratio (wt/vol), and total
nucleic acid was extracted from 200 μL of each stool sus-
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pension by the MagNAPure LC Automated Nucleic Acid
Extraction System (Roche, Indianapolis, IN, USA).
Previously described astrovirus primers Mon269 and
Mon270 (11) frequently have been used for detecting human astrovirus serotypes 1–8 in clinical stool specimens.
However, the extensive divergence of AstV-MLB1 to the
known human astroviruses rendered these primers unable
to amplify AstV-MLB1 (data not shown). Because AstVMLB1 might represent a new grouping of astroviruses that
could include multiple subtypes, we designed primers to
conserved regions of the AstV-MLB1 genome to maximize
the likelihood of detecting any AstV-MLB1 variant viruses
or even other novel astroviruses.
We identified conserved regions by using multiple sequence alignments of AstV-MLB1 amino acid sequences to
all fully sequenced astrovirus genomes (Figure 1, panels A
and B). The corresponding nucleotide sequences for these regions were then aligned to define the most highly conserved
regions (Figure 1, panels C and D). Two regions within open
reading frame (ORF) 1b were identified that yielded primers SF0073 (5′-GATTGGACTCGATTTGATGG-3′) and
SF0076 (5′-CTGGCTTAACCCACATTCC-3′), which are
predicted to generate an ≈409-bp product. Control experiments validated this primer pair could detect AstV-MLB1,
as well as human astrovirus 1 (online Appendix Figure,
available from www.cdc.gov/EID/content/15/3/441-appF.
htm). Given that some of the canonical human astroviruses
are identical in the primer binding sites, these data suggest
that at least some of the canonical human astroviruses can
be detected by the primer pair SF0073/SF0076. In theory,
under appropriate experimental conditions, these primers
also may be able to detect all other known human and animal astroviruses, although that remains to be experimentally tested. These primers were used with the QIAGEN
One-Step RT-PCR Kit (QIAGEN, Valencia, CA, USA) by
using the following cycling conditions: 30 min RT step,
94ºC for 10 min, followed by 40 cycles of 94ºC for 30 s,
52ºC for 30 s, and 72ºC for 50 s.
Samples that tested positive with primers SF0073
and SF0076 were then tested in a second round of screening with 2 different primer sets in parallel to determine
whether the samples contained canonical human astrovirus serotypes 1–8 or AstV-MLB1. The previously reported Mon269 (5′-CAACTCAGGAAACAGGGTGT-3′) and
Mon270 (5′-TCAGATGCATTGTCATTGGT-3′) primers,
which generate a 449-bp amplicon, were used to detect canonical human astroviruses (11). Another set of primers,
SF0053 (5′-CTGTAGCTCGTGTTAGTCTTAACA-3′)
and SF0061 (5′-GTTCATTGGCACCATCAGAAC-3′),
was designed to exclusively detect AstV-MLB1 and produce a 402-bp PCR product. These primers target a region of the capsid gene. The second round of screening
with both sets of primer pairs was performed as described
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Figure 1. Astrovirus open reading frame (ORF) 1b alignments for design of pan-astrovirus primers. Astrovirus RNA polymerase sequences
(ORF1b) were aligned at the amino acid level to define the conserved regions used for the design of primers SF0073 (A) and SF0076 (B).
The numbers to the right of the sequences indicate the position of the last amino acid within each ORF1b sequence. Red boxes represent
the specific regions that were reverse translated into the corresponding nucleic acid sequences used for the design of SF0073 (C) and
SF0076 (D). Red sequences shown in the nucleotide alignments are the actual primer sequences. Asterisks indicate nucleotide identity.

above except that an annealing temperature of 56ºC was
used.
Of 254 stool specimens screened, 9 (3.5%) tested positive in the initial round of screening that used the newly
designed pan-astrovirus primers, SF0073 and SF0076.
Secondary screening showed that 5 (2% of all samples)
were canonical human astroviruses. This probably underestimates the prevalence of the astrovirus serotype 1–8 in
the cohort because the initial screening primers were biased toward detection of AstV-MLB1. The remaining 4
(1.6% of all samples) were positive for AstV-MLB1 using primers SF0053 and SF0061. For each of the 4 samples positive for AstV-MLB1, 2 additional fragments

were generated by RT-PCR for phylogenetic analysis.
A 1,228-bp fragment of ORF1a, which encodes the serine protease, and a 920-bp fragment of ORF2, which
encodes the capsid proteins, were amplified using AstVMLB1–specific primers from each of the 4 samples designated WD0016, WD0055, WD0104, and WD0227.
The primers used for the ORF1a fragment are SF0080
(5′-AAGGATAGTGCTGGTAAAGTAGTTCAGA-3′)
and SF0094 (5′-CAAGAGCCTTATCAACAACGTA-3′)
and the primers used for the ORF2 fragment are SF0064
(5′-GTAAGCATGGTTCTTGTGGAC-3′) and SF0098
(5′-TGCATACATTTATGCTGGAAGA-3′). The ORF1a
fragments (GenBank accession nos. FJ227120–FJ227123)
Figure 2. Phylogenetic analysis of
astrovirus MLB1 (AstV-MLB1) isolates. A
region of the serine protease (A) and the
capsid (B) of each virus detected by the
AstV-MLB1–specific primers was amplified
and sequenced. Multiple sequence
alignments were then generated with
these sequences and the corresponding
regions of known astroviruses using
ClustalX
(www.clustal.org).
PAUP*
(Sinauer Associates, Sunderland, MA,
USA) was used to generate phylogenetic
trees; bootstrap values (>700) from 1,000
replicates are shown. The previously
identified AstV-MLB1 isolate (9,10) and
the isolates from this study are shown in
boldface. Scale bars indicate number of
amino acid substitutions per site.
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Table 1. Similarity of fully sequenced WD0016 genome to AstVMLB1*
Nucleotide identity with AstV-MLB1, %
ORF1a
ORF1b
ORF2
Genome
(serine protease) (RNA polymerase) (capsid)
WD0016
92.6
93.9
91.9
*AstV-MLB1, astrovirus MLB1; ORF, open reading frame.

from these samples all shared ≈92% nt identity to the reference astrovirus MLB1 sequence (GenBank accession no.:
FJ222451) and 99% aa identity, indicating that most mutations were synonymous. The ORF2 fragments (GenBank
accession nos. FJ227124–FJ227127) shared ≈91%–92% nt
identity and 95%–96% aa identity to the reference astrovirus MLB1 sequence. The 4 positive St. Louis samples
shared ≈99% nt identity to each other. The ORF1a and
ORF2 sequences were aligned to other astroviruses for
which full genome sequences were available using ClustalX version 1.83 (www.clustal.org); maximum-parsimony
trees were generated using PAUP with 1,000 bootstrap replicates (12) (Figure 2). The entire genome of one of the
isolates, WD0016 (GenBank accession no. FJ402983),
was sequenced and had 92.6% identity overall to that of
AstV-MLB1 on the basis of a pairwise nucleotide alignment (Table 1).
Patients with AstV-MLB1–positive stools ranged in age
from ≈4 months to 4 years (Table 2). All patients had symptoms of diarrhea at stool collection, except the patient with
isolate WD0016, who reported having diarrhea 2 days before
stool collection. All specimens were tested for Escherichia
coli, Campylobacter spp., Yersinia spp., Shigella spp., and
Salmonella spp. by standard bacterial culture. The WD0227
sample tested positive for E. coli O157:H7; the other samples were negative for all bacterial cultures. A pan-viral microarray, the ViroChip (GEO platform GPL 3429; National
Center for Biotechnology Information, Bethesda, MD, USA)
(13), was used to examine whether other viruses were present in the stool of 3 (WD0055, WD0104, and WD0227) of
the 4 AstV-MLB1–positive samples for which enough material remained for analysis. WD0055 and WD0104 were
negative by array, but WD0227 was positive for rotavirus as
determined by the ViroChip.

Conclusions
The newly identified AstV-MLB1 virus was discovered in a stool specimen collected in Melbourne, Victoria,
Australia, in 1999. In this study, we describe the detection of AstV-MLB1 in a cohort from St. Louis collected in
2008. This observation provides evidence of AstV-MLB1
outside Australia and suggests that AstV-MLB1 is likely to
be globally widespread. In addition, these data demonstrate
that AstV-MLB1 is circulating in the human population.
The sequence divergence of ≈8% at the nucleotide level
between the reference AstV-MLB1 genome and the viruses
detected in this study suggests substantial sequence heterogeneity within the AstV-MLB1 group of viruses. Multiple
serotypes or subtypes of AstV-MLB1 might exist, as with
the canonical human astroviruses. More extensive screening
of stool samples with PCR primers targeted toward detection of AstV-MLB1, such as those described here, may provide insight into the true diversity and prevalence of AstVMLB1–like viruses. Finally, a critical direction for future
investigation is determining whether AstV-MLB1, like the
canonical astrovirus serotypes 1–8, is a causal agent of human diarrhea, and if so, assessing the extent and severity of
disease associated with this virus. Further epidemiologic
studies, including both case–control prevalence studies and
seroprevalence assays, and efforts to fulfill Koch’s postulates should be pursued.
This work was supported in part by National Institutes of
Health grant U54 AI057160 to the Midwest Regional Center of
Excellence for Biodefense and Emerging Infectious Diseases Research and under Ruth L. Kirschstein National Research Service
Award 5 T32 DK077653 from the National Institute of Diabetes
and Digestive and Kidney Diseases.
Ms Finkbeiner is a graduate student at Washington University in St. Louis in the Molecular Microbiology and Microbial
Pathogenesis Program. Her research focuses on the identification
and characterization of novel viruses found in diarrhea.

Table 2. Clinical and demographic characteristics of patients with stool samples positive for astrovirus MLB1
Sample
Characteristic
WD0016
WD0055
WD0104
Age, m
15
17
4
Sex
F
F
M
Diarrhea
No*
Yes
Yes
Other symptoms
Abdominal pain
Vomiting, fever
Fever, seizures,
respiratory distress
Hospitalization
Yes
No
Yes
Bacterial cultures†
Negative
Negative
Negative

WD0227
43
M
Yes
Fever
Yes
Positive for E. coli
O157:H7

*Patient had diarrhea 2 days before stool collection but not at collection.
†Tests were conducted for Escherichia coli, Campylobacter spp., Shigella spp., Salmonella spp., and Yersinia spp.
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